MarketCap
Facebook
X
TelegramCantel Medical Corp. Revenue 2011-2025 | CMD
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Cantel Medical Corp.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.02 B | 918 M | 872 M | 770 M | 665 M | 565 M | 489 M | 425 M | 386 M | 322 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.02 B | 322 M | 643 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical instruments industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
82.3 M | $ 24.39 | - | $ 1.12 B |  USA |
 |
Baxter International
BAX
|
2.75 B | $ 19.68 | 2.77 % | $ 10 B | USA |
 |
Becton, Dickinson and Company
BDX
|
21.8 B | $ 200.26 | -0.34 % | $ 57.6 B | USA |
 |
Luminex Corporation
LMNX
|
417 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.58 M | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
17.9 M | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
150 M | - | - | $ 955 M | USA |
 |
CRH Medical Corporation
CRHM
|
106 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.88 B | - | -0.05 % | $ 10.3 B | USA |
 |
Harvard Bioscience
HBIO
|
112 M | $ 0.71 | -3.6 % | $ 30.1 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
3.17 B | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
2.38 B | $ 147.79 | -0.43 % | $ 3.6 B | USA |
 |
Alcon
ALC
|
9.91 B | $ 79.23 | 0.53 % | $ 40.4 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
592 M | $ 171.52 | 1.59 % | $ 5.35 B | USA |
 |
AtriCure
ATRC
|
465 M | $ 41.41 | -2.29 % | $ 1.94 B | USA |
 |
Atrion Corporation
ATRI
|
169 M | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
16 M | $ 4.8 | 1.05 % | $ 26.5 K | USA |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 5.8 | 0.35 % | $ 264 M | USA |
 |
AngioDynamics
ANGO
|
292 M | $ 13.38 | 1.83 % | $ 547 M | USA |
 |
The Cooper Companies
COO
|
4.09 B | $ 81.12 | -1.17 % | $ 16.2 B | USA |
 |
LeMaitre Vascular
LMAT
|
220 M | $ 83.58 | -0.5 % | $ 1.88 B | USA |
 |
Glaukos Corporation
GKOS
|
315 M | $ 111.86 | 2.72 % | $ 5.42 B | USA |
 |
Haemonetics Corporation
HAE
|
1.36 B | $ 78.81 | -5.6 % | $ 3.97 B | USA |
 |
InfuSystem Holdings
INFU
|
110 M | $ 9.18 | -0.65 % | $ 190 M | USA |
 |
Masimo Corporation
MASI
|
2.09 B | $ 136.6 | -1.25 % | $ 7.28 B | USA |
 |
Isoray
ISR
|
3.55 M | - | 0.03 % | $ 108 M | USA |
 |
Merit Medical Systems
MMSI
|
1.36 B | $ 85.98 | -0.83 % | $ 5.01 B | USA |
 |
Intuitive Surgical
ISRG
|
8.35 B | $ 554.57 | 2.26 % | $ 197 B | USA |
 |
OraSure Technologies
OSUR
|
186 M | $ 2.48 | -0.25 % | $ 185 M | USA |
 |
Microbot Medical
MBOT
|
117 K | $ 2.25 | -6.64 % | $ 22.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
8.63 M | $ 0.37 | -5.12 % | $ 29.5 M | USA |
 |
Nephros
NEPH
|
14.2 M | $ 4.96 | -1.29 % | $ 51.5 M | USA |
 |
NeuroMetrix
NURO
|
3.03 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.51 B | $ 22.01 | 0.16 % | $ 3.79 B | USA |
 |
ResMed
RMD
|
3.58 B | $ 252.48 | 0.05 % | $ 36.9 B | USA |
 |
Pro-Dex
PDEX
|
66.6 M | $ 42.14 | -2.86 % | $ 139 M | USA |
 |
STAAR Surgical Company
STAA
|
314 M | $ 23.59 | -2.24 % | $ 1.16 B | USA |
 |
STERIS plc
STE
|
5.46 B | $ 252.72 | 0.32 % | $ 24.9 B | USA |
 |
Stereotaxis
STXS
|
26.8 M | $ 2.36 | -0.42 % | $ 190 M | USA |
 |
Pulse Biosciences
PLSE
|
700 K | $ 14.04 | -1.44 % | $ 674 M | USA |
 |
Predictive Oncology
POAI
|
1.62 M | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
632 M | $ 158.66 | 0.81 % | $ 8.84 M | USA |
 |
Utah Medical Products
UTMD
|
12.3 M | $ 58.21 | 0.19 % | $ 211 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
3.79 B | $ 11.38 | -1.69 % | $ 2.31 B | USA |
 |
Retractable Technologies
RVP
|
33 M | $ 0.84 | 2.04 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
3.05 B | $ 126.36 | -0.24 % | $ 5.92 B | USA |
 |
West Pharmaceutical Services
WST
|
2.89 B | $ 270.21 | 0.99 % | $ 19.7 B | USA |